(Q43654229)

English

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

7

object named as

Hamsten A

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Marja-Riitta Taskinen

2

object named as

Taskinen MR

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Nieminen MS

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Frick MH

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kesäniemi YA

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Pasternack A

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Syvänne M

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

157

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

181-187

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Tr

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Postprandial lipoproteins and progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT St

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

Plasma triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900700-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(00)00700-0

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

release_pujglk27ive2nbe7ns3tt2j42i

1 reference

https://api.fatcat.wiki/v0/release/pujglk27ive2nbe7ns3tt2j42i

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43654229&oldid=2102343157"